BACKGROUND: Foot infections are limb-threatening complications in patients with diabetes mellitus (DM), and proper classification of the severity of diabetic foot infection (DFI) is important in determining an effective antibiotic regimen, the need for hospitalization and surgery, and the risk of amputation. Our hypothesis was that patients with severe DFI would have a longer hospitalization than those with moderate DFI. The purposed of this study was 2-fold. The first purpose was to define DFI using readily available clinical information and objective parameters outlined by consensus statements. The second purpose of this study was to assess rates of amputation and limb salvage for hospitalized patients with DFI. METHODS: The database of a single academic foot and ankle program was reviewed for patients who were hospitalized for a DFI from 2006 to 2011. Inpatient and outpatient electronic medical records identified 100 patients. Severe DFI was defined as having 2 or more objective findings of systemic toxicity and/or metabolic instability at the time of initial assessment. RESULTS: The length of stay was significantly shorter for patients with a moderate infection than for those with a severe infection (median 5 days vs 8 days, P = .021). A nonsignificant trend was observed that indicated higher rates of limb salvage in patients with moderate infections compared with patients with severe infections (94% vs 80%, P = .081). CONCLUSION: Patients with severe DFI had a median hospital stay that was 60% longer than that of patients with moderate DFI. In this sample, 55% of patients with a severe DFI required some type of amputation compared with 42% of patients with a moderate DFI. LEVEL OF EVIDENCE: Level III, retrospective control cohort study.
BACKGROUND:Foot infections are limb-threatening complications in patients with diabetes mellitus (DM), and proper classification of the severity of diabetic foot infection (DFI) is important in determining an effective antibiotic regimen, the need for hospitalization and surgery, and the risk of amputation. Our hypothesis was that patients with severe DFI would have a longer hospitalization than those with moderate DFI. The purposed of this study was 2-fold. The first purpose was to define DFI using readily available clinical information and objective parameters outlined by consensus statements. The second purpose of this study was to assess rates of amputation and limb salvage for hospitalized patients with DFI. METHODS: The database of a single academic foot and ankle program was reviewed for patients who were hospitalized for a DFI from 2006 to 2011. Inpatient and outpatient electronic medical records identified 100 patients. Severe DFI was defined as having 2 or more objective findings of systemic toxicity and/or metabolic instability at the time of initial assessment. RESULTS: The length of stay was significantly shorter for patients with a moderate infection than for those with a severe infection (median 5 days vs 8 days, P = .021). A nonsignificant trend was observed that indicated higher rates of limb salvage in patients with moderate infections compared with patients with severe infections (94% vs 80%, P = .081). CONCLUSION:Patients with severe DFI had a median hospital stay that was 60% longer than that of patients with moderate DFI. In this sample, 55% of patients with a severe DFI required some type of amputation compared with 42% of patients with a moderate DFI. LEVEL OF EVIDENCE: Level III, retrospective control cohort study.
Authors: Benjamin A Lipsky; Anthony R Berendt; H Gunner Deery; John M Embil; Warren S Joseph; Adolf W Karchmer; Jack L LeFrock; Daniel P Lew; Jon T Mader; Carl Norden; James S Tan Journal: Clin Infect Dis Date: 2004-09-10 Impact factor: 9.079
Authors: B A Lipsky; E J G Peters; E Senneville; A R Berendt; J M Embil; L A Lavery; V Urbančič-Rovan; W J Jeffcoate Journal: Diabetes Metab Res Rev Date: 2012-02 Impact factor: 4.876
Authors: Peter G Noordzij; Eric Boersma; Frodo Schreiner; Miklos D Kertai; Harm H H Feringa; Martin Dunkelgrun; Jeroen J Bax; Jan Klein; Don Poldermans Journal: Eur J Endocrinol Date: 2007-01 Impact factor: 6.664
Authors: Lawrence A Lavery; David G Armstrong; Douglas P Murdoch; Edgar J G Peters; Benjamin A Lipsky Journal: Clin Infect Dis Date: 2007-01-17 Impact factor: 9.079
Authors: Benjamin A Lipsky; Anthony R Berendt; Paul B Cornia; James C Pile; Edgar J G Peters; David G Armstrong; H Gunner Deery; John M Embil; Warren S Joseph; Adolf W Karchmer; Michael S Pinzur; Eric Senneville Journal: Clin Infect Dis Date: 2012-06 Impact factor: 9.079
Authors: George A Kaysen; Joel A Dubin; Hans-Georg Müller; Laura Rosales; Nathan W Levin; William E Mitch Journal: Kidney Int Date: 2004-04 Impact factor: 10.612
Authors: Benjamin A Lipsky; Peter Sheehan; David G Armstrong; Alan D Tice; Adam B Polis; Murray A Abramson Journal: Int Wound J Date: 2007-03 Impact factor: 3.315
Authors: Michael S Pinzur; Rodney M Stuck; Ronald Sage; Nathan Hunt; Zinoviy Rabinovich Journal: J Bone Joint Surg Am Date: 2003-09 Impact factor: 5.284
Authors: Benjamin A Lipsky; John A Weigelt; Xiaowu Sun; Richard S Johannes; Karen G Derby; Ying P Tabak Journal: Diabetes Care Date: 2011-06-16 Impact factor: 19.112
Authors: Bao G Vu; Christopher S Stach; Wilmara Salgado-Pabón; Daniel J Diekema; Sue E Gardner; Patrick M Schlievert Journal: J Infect Dis Date: 2014-06-20 Impact factor: 5.226
Authors: Sue E Gardner; Ambar Haleem; Ying-Ling Jao; Stephen L Hillis; John E Femino; Phinit Phisitkul; Kristopher P Heilmann; Shannon M Lehman; Carrie L Franciscus Journal: Diabetes Care Date: 2014-07-10 Impact factor: 19.112
Authors: Bao G Vu; Francoise A Gourronc; David A Bernlohr; Patrick M Schlievert; Aloysius J Klingelhutz Journal: PLoS One Date: 2013-10-30 Impact factor: 3.240
Authors: Gianmarco Matta-Gutiérrez; Esther García-Morales; Yolanda García-Álvarez; Francisco Javier Álvaro-Afonso; Raúl Juan Molines-Barroso; José Luis Lázaro-Martínez Journal: J Clin Med Date: 2021-05-01 Impact factor: 4.241